ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 230 filers reported holding ICU MED INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,289,994 | -33.6% | 44,450 | -0.5% | 0.00% | -50.0% |
| Q2 2023 | $7,961,529 | -2.9% | 44,680 | -10.1% | 0.00% | 0.0% |
| Q1 2023 | $8,199,666 | -62.1% | 49,707 | -63.8% | 0.00% | -66.7% |
| Q4 2022 | $21,611,295 | +14.8% | 137,232 | +9.8% | 0.01% | 0.0% |
| Q3 2022 | $18,817,000 | -11.4% | 124,944 | -3.3% | 0.01% | 0.0% |
| Q2 2022 | $21,243,000 | -21.0% | 129,228 | +7.0% | 0.01% | -14.3% |
| Q1 2022 | $26,879,000 | -1.3% | 120,732 | +5.2% | 0.01% | 0.0% |
| Q4 2021 | $27,228,000 | -42.5% | 114,719 | -43.5% | 0.01% | -41.7% |
| Q3 2021 | $47,353,000 | +13.3% | 202,902 | -0.1% | 0.01% | +20.0% |
| Q2 2021 | $41,782,000 | -2.4% | 203,030 | -2.6% | 0.01% | -9.1% |
| Q1 2021 | $42,829,000 | -5.7% | 208,465 | -1.6% | 0.01% | -15.4% |
| Q4 2020 | $45,420,000 | +128.2% | 211,757 | +94.5% | 0.01% | +85.7% |
| Q3 2020 | $19,902,000 | +2.7% | 108,893 | +3.5% | 0.01% | 0.0% |
| Q2 2020 | $19,382,000 | -16.0% | 105,161 | -8.1% | 0.01% | -30.0% |
| Q1 2020 | $23,079,000 | +27.7% | 114,383 | +18.4% | 0.01% | +66.7% |
| Q4 2019 | $18,078,000 | -7.5% | 96,620 | -21.1% | 0.01% | +20.0% |
| Q3 2019 | $19,535,000 | -81.9% | 122,396 | -71.4% | 0.01% | -82.1% |
| Q2 2019 | $107,876,000 | +34.8% | 428,233 | +28.1% | 0.03% | +3.7% |
| Q1 2019 | $80,014,000 | +5.2% | 334,329 | +1.0% | 0.03% | -6.9% |
| Q4 2018 | $76,042,000 | -19.8% | 331,153 | -1.3% | 0.03% | -3.3% |
| Q3 2018 | $94,842,000 | +8.5% | 335,425 | +12.7% | 0.03% | +3.4% |
| Q2 2018 | $87,418,000 | +35.7% | 297,698 | +16.6% | 0.03% | +20.8% |
| Q1 2018 | $64,418,000 | -13.7% | 255,221 | -26.1% | 0.02% | -11.1% |
| Q4 2017 | $74,611,000 | +23.0% | 345,420 | +5.8% | 0.03% | +22.7% |
| Q3 2017 | $60,669,000 | +9.0% | 326,437 | +1.2% | 0.02% | +29.4% |
| Q2 2017 | $55,664,000 | +8.9% | 322,682 | -3.6% | 0.02% | 0.0% |
| Q1 2017 | $51,131,000 | +4.6% | 334,850 | +0.9% | 0.02% | +6.2% |
| Q4 2016 | $48,904,000 | +20.3% | 331,887 | +3.2% | 0.02% | +14.3% |
| Q3 2016 | $40,662,000 | +640.3% | 321,744 | +560.4% | 0.01% | +600.0% |
| Q2 2016 | $5,493,000 | -12.9% | 48,718 | -19.6% | 0.00% | -33.3% |
| Q1 2016 | $6,306,000 | -19.2% | 60,577 | -12.4% | 0.00% | 0.0% |
| Q4 2015 | $7,802,000 | +8.1% | 69,182 | +5.0% | 0.00% | 0.0% |
| Q3 2015 | $7,216,000 | +76.6% | 65,904 | +54.3% | 0.00% | +50.0% |
| Q2 2015 | $4,087,000 | +16.2% | 42,725 | +13.2% | 0.00% | +100.0% |
| Q1 2015 | $3,517,000 | +4.0% | 37,757 | -8.6% | 0.00% | 0.0% |
| Q4 2014 | $3,383,000 | +39.6% | 41,308 | +9.4% | 0.00% | 0.0% |
| Q3 2014 | $2,424,000 | +3.9% | 37,764 | -1.5% | 0.00% | 0.0% |
| Q2 2014 | $2,332,000 | -16.1% | 38,353 | -17.4% | 0.00% | 0.0% |
| Q1 2014 | $2,780,000 | +2.2% | 46,417 | +8.7% | 0.00% | 0.0% |
| Q4 2013 | $2,720,000 | -12.9% | 42,688 | -7.1% | 0.00% | 0.0% |
| Q3 2013 | $3,122,000 | +1.8% | 45,949 | +8.0% | 0.00% | 0.0% |
| Q2 2013 | $3,066,000 | – | 42,546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |